NCT02580240View on ClinicalTrials.gov

Initiation of Hydrocortisone for the Treatment of Septic Shock

NACompletedINTERVENTIONAL
Enrollment

118

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

September 30, 2016

Study Completion Date

December 31, 2016

Conditions
Septic Shock
Interventions
DRUG

Hydrocortisone

Hydrocortisone was administered 200 mg/d as a continuous infusion for 6d, then tapered off. Once all vasopressors were discontinued, the taper protocol was initiated (half dose for three days, then quarter dose for three days and then stopped).

DRUG

saline

Vials containing normal saline as placebo were identical to those containing hydrocortisone. Placebo administration procedures were similar.

Trial Locations (1)

225000

Northern Jiangsu Province people's hospital, Yangzhou

All Listed Sponsors
lead

Northern Jiangsu People's Hospital

OTHER

NCT02580240 - Initiation of Hydrocortisone for the Treatment of Septic Shock | Biotech Hunter | Biotech Hunter